Cannabis Law Report

FEBRUARY 5, 2022

Drug Enforcement Administration (DEA) this week challenging the government’s Schedule I classification of psilocybin, the main psychoactive component of psychedelic mushrooms. Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use. Marijuana Moment. As part of the suit, attorneys general from eight U.S.

DEA 52

DEA Patients Marijuana 52

Cannabis Law Report

MARCH 7, 2020

In its performance budget submission to Congress for fiscal year 2021, DEA gave an overview of its enforcement efforts and made predictions about future trends. Buried within the document is a subtle admission that giving consumers legal access to cannabis means that demand for marijuana products sourced from the illegal market decreases.

DEA 64

DEA THC Retail Access 64

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

MassRoots

NOVEMBER 19, 2018

The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. But due to inadequate record keeping, the DEA doesn’t really know if that money is serving its purpose. each year to help them get rid of illegal cannabis grows.

DEA 64

DEA Programs Marijuana Collective 64

Cannabis Law Report

MARCH 17, 2021

We start you off with the LETTER FROM THE ACTING ADMINISTRATOR It is my privilege to present the 2020 National… Read More.

DEA 59

DEA 59

SpeedWeed

SEPTEMBER 4, 2021

The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

FEBRUARY 16, 2022

A 28-page DEA report — authored in August of 2021, and based on Department of Health and Human Services reviews of these psychedelics from 2012 — states, “These five tryptamines have no known medical use in the United States and are not marketed internationally as approved drug products. Read full report at.

DEA 52

DEA Safety Treatment Law 52

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling.

DEA 98

DEA Marijuana History Cannabis 98

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. Leafly’s Ben Adlin documented the shockingly poor quality in this 2017 article : Smoking 25% THC, studying 8% THC. DEA finally relents.

DEA 52

DEA Research and Development Data Cannabis 52

Medical Marijuana Program Connection

JANUARY 19, 2024

The Chicago-based company has … recommendation that the DEA reschedule marijuana – including 252 pages of … (when the DEA last rejected marijuana rescheduling). Will having government documentation … Original Author Link click here to read complete story. Read More

DEA 45

DEA Marijuana Business 45

SpeedWeed

MARCH 10, 2021

Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.

DEA 52

DEA Hemp Cannabinoids Legalization 52

Medical Marijuana Program Connection

JANUARY 14, 2024

Schedule I drugs are defined by the DEA as substances with no “currently accepted medical use and a high potential for abuse.” With Friday’s release of documents related to the Department of Health and Human Service’s (HHS). The list includes heroin, LSD, ecstasy, meth, peyote, and, for the past 24 years, cannabis. Read More

DEA 45

DEA Cannabis Legalization 45

The Blunt Truth

DECEMBER 15, 2023

The Department of Health and Human Services released documents related to rescheduling cannabis. The DEA sends a letter to Georgia pharmacies. The documents are heavily redacted, so you may glean less information than you might think. Ohio legislators are busy writing a marijuana law. makes an appearance in Congress.

DEA 59

DEA Legislation Legalization Consumption 59

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). When pressed by CEC’s lawyers, CBP was able to sort through these 966 and identify information in the seizure documents that identified the seized materials as brown liquid or brown paste. Customs Border Patrol (“CBP”) and U.S. Department of the Navy , 562 U.S. 562 [2011]).

DEA 97

DEA Blood Pressure Safety Policy 97

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Canna Law Blog

SEPTEMBER 3, 2020

This summer, the DOJ and the DEA sued the BCC because the BCC refused to comply with a DEA subpoena about the alleged extracurricular drug trafficking above. The BCC has refused to provide that information to the DEA. In the January subpoena (which is standard and boilerplate), the DEA wrote that “the information sought.

DEA 97

DEA Compliance Compliance Law 97

Cannabis Law Report

SEPTEMBER 2, 2021

Court of Appeals for the Ninth Circuit dismissed a petition brought by a team of cannabis researchers, scientists, and military veterans to require that the Drug Enforcement Administration (DEA) reevaluate marijuana’s status as a Schedule I substance under the Controlled Substances Act (CSA). The case before the Ninth Circuit, Sidley v.

DEA 102

DEA Marijuana Treatment Legalization 102

Cannabis Law Report

JANUARY 30, 2019

The introduction to the document… The Honorable Lindsey Graham. Access the full document at. We’ve quickly scanned the document and highlight a few of the following passages of relevance. Access the full document at. Chairman Committee on the Judiciary United States Senate Washington, DC 20510.

Research and Development 63

Research and Development DEA CBD Law 63

Veriheal

JUNE 30, 2023

The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

TheAnswerPage

DECEMBER 9, 2021

Has the Drug Enforcement Administration (DEA) issued any statements about the legal “loop hole” in the Farm Bill and the production and sale of ?8-THC? The DEA specifically lists ?8-THC In contrast, the Farm Bill “does not impact the control status of synthetically derived tetrahydrocannabinols.” 2021.0097.

DEA 52

DEA Agriculture Safety THC 52

Medicinal Genomics

NOVEMBER 5, 2019

However, the document also states “the cut shall be made just underneath a flowering material”. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. New Sampling Guidelines. This guidance is in line with the common international standards.

THC 81

THC Hemp DEA Banking 81

Canna Law Blog

AUGUST 21, 2020

Although the Second Circuit expressed considerable skepticism of the drug scheduling regime, the court held that before plaintiffs could seek relief in federal court, they must first file a de-scheduling petition with the DEA. At this point, readers may be asking: Why didn’t the plaintiffs file a petition with the DEA? Petition at 3.

DEA 69

DEA Marijuana Pharmaceutical Cannabis 69

Canna Law Blog

JULY 17, 2020

A: OK, after your get the IRB approval letter, you need permission from the Drug Enforcement Agency (DEA)– Q: Hold on. But it’s set up so that DEA works with FDA and its parent, the Department of Health and Human Services (HHS), to schedule and control all of these substances. How do I get DEA permission?

DEA 85

DEA Research and Development Therapy Banking 85

PrestoDoctor

FEBRUARY 6, 2023

Documentation Needed for the Application All requested documentation must be valid and unexpired. You must provide all these documents as digital or color copies. That is to say, if the documents have expired they will not be valid and will not count. The DEA does not know who has MMJs and no actual database exists.

Marijuana 52

Marijuana Patients Conditions Access 52

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. A cannabis prescription is a legal document that allows you to obtain medical marijuana. A cannabis prescription is a prescription written by a doctor to be used as medical marijuana.

DEA 52

DEA Patients Conditions Cannabis 52

Cannabis Law Report

NOVEMBER 4, 2021

The President could pursue the appointment of agency officials who favor descheduling, or use executive orders to direct DEA, HHS, and FDA to consider administrative descheduling of marijuana. The CRS specifically addresses the Executive Branch’s abilities to remove marijuana from the Controlled Substances Act: . We’re beyond that.”.

DEA 52

DEA Marijuana Decriminalization Data 52

Cannabis Law Report

NOVEMBER 3, 2021

According to court documents, from 2017 through November 2019, Joseph Ruis, 56, was the leader of a Southern California-based wholesale spice manufacturing and distribution operation, along with co-defendants and sisters Kimberly Drumm, 52, and Bonnie Turner, 50, of Olive Branch, Mississippi. Postal Inspection Service; and Robert P.

Cannabinoids 98

Cannabinoids Packaging DEA Law 98

Greenspoon Marder Cannabis Law Group Blog

OCTOBER 30, 2019

The regulation is 161 pages in length and is accompanied by two separate guidance documents covering sampling and testing. DEA will continue to have a role in the hemp program. The regulation requires that testing be done by a DEA registered lab and that in the disposal of hemp above 0.3% must be accomplished under DEA guidance.

Hemp 40

Hemp DEA Programs History 40

Cannabis Law Report

MAY 26, 2022

The first argument was that according to the DEA, Delta-8 remains a schedule I substance because its method of manufacture is “synthetically-derived.” This document may be considered attorney advertising in some jurisdictions. In other words, any contrary agency language is overridden by clear statutory text. © 2022 THOMPSON HINE LLP.

THC 52

THC Hemp DEA Consumption 52

Canna Law Blog

JULY 24, 2020

Although the guidance does not cover other FDA-regulated products, such as hemp-derived CBD (“Hemp CBD”)-infused foods and dietary supplements, the last section of the document – Section III C. Some manufacturing processes may generate materials, such as intermediates or accumulated by-products, that exceed the 0.3

CBD 92

CBD Research and Development DEA Concentrates 92

SpeedWeed

MARCH 21, 2021

When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.

DEA 52

DEA Cannabinoids Research and Development THC 52

Canna Law Blog

DECEMBER 4, 2019

Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 15-day preharvest testing by a DEA registered laboratory. Snyder’s findings should alarm everyone in the hemp industry. Your Comments Matter.

Hemp 70

Hemp DEA CBD THC 70

Cannabis Law Report

APRIL 18, 2019

Sacramento New & Review have detailed the DEA, FBI and IRS investigations and written a piece well worth reading if you want to understand how difficult it is going to be to dig out the entrenched black sector of cannabis in California. It’s incredibly unique,” DEA Special Agent in Charge Chris Nielson said of Chinese cash flows. “We

Banking 55

Banking DEA Legalization Marijuana 55

SpeedWeed

MARCH 21, 2021

When asked if that’s because of language from the Drug Enforcement Administration (DEA) that states that tetrahydrocannabinols are illegal when synthetically produced from cannabis, he said, “Right, that’s true. Delta-8 isn’t mentioned by name in the 2018 Farm Bill, the DEA’s IFR or the Controlled Substances Act.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

MedicalJane

JUNE 29, 2018

Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. Perhaps surprising to some, Rite Aid told CNNMoney that it would sell Epidiolex once the DEA schedules it.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53